Download Disease Area Studied Drug Name Study ID Title Phase Result

Disease Area
Studied
Drug Name
Study ID
Title
Phase
Result Details
Acute Coronary
Syndromes
Clopidogrel
Bisulfate
CV149-015 ST
A Randomized, III
Double-Blind,
PlaceboControlled Trial
Comparing
Clopidogrel Plus
Acetylsalicylic
Acid (Asa)
Versus Asa
Alone In Subjects
With Acute St
Elevation
Myocardial
Infarction (Stemi)
Treated With
Fibrinoyltic
Therapy
Publication
Reference Result
Acute Coronary
Syndromes
Clopidogrel
Bisulfate
CV149-208 ST
An Exploratory, IV
Multi-Center,
Open Label,
Single Arm Study
To Evaluate The
Discontinuation
Effect Of
Clopidogrel After
Drug Eluting
Stent (Decades)
On Inflammatory
And Platelet
Activation
Markers In
Subjects Who
Are Receiving
Low Dose
Acetylsalicylic
Acid.
Publication
Reference Result
© 2013 Bristol-Myers Squibb Company.
Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy
1
Anticoagulation
Eliquis
CV185-030 ST
A Phase 3, Active III
(Warfarin)
Controlled,
Randomized,
Double-Blind,
Parallel Arm
Study To
Evaluate Efficacy
And Safety Of
Apixaban In
Preventing
Stroke And
Systemic
Embolism In
Subjects With
Nonvalvular Atrial
Fibrillation.
Publication
Reference Result
Anticoagulation
Eliquis
CV185-035 ST
A Phase 3
III
Randomized,
Double-Blind,
Active-Controlled
(Enoxaparin),
Parallel-Group,
Multi-Center
Study To
Evaluate The
Safety And
Efficacy Of Oral,
Apixaban (2.5 Mg
Bid) In Subjects
Undergoing
Elective Total Hip
Replacement
Surgery
Publication
Reference Result
Anticoagulation
Eliquis
CV185-036 ST
A Phase 3
III
Randomized,
Double-Blind,
Parallel-Group,
Multi-Center
Study Of The
Safety And
Efficacy Of
Apixaban For
Prophylaxis Of
Venous
Thromboembolis
m In Acutely Ill
Medical Subjects
During And
Following
Hospitalization.
Publication
Reference Result
© 2013 Bristol-Myers Squibb Company.
Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy
2
Anticoagulation
Eliquis
CV185-047 ST
A Phase 3,
III
Randomized,
Double-Blind,
Active-Controlled
(Enoxaparin 40
Mg Qd), ParallelGroup, MultiCenter Study To
Evaluate The
Safety And
Efficacy Of
Apixaban In
Subjects
Undergoing
Elective Total
Knee
Replacement
Surgery (The
Advance - 2
Study)
Publication
Reference Result
Anticoagulation
Eliquis
CV185-048 ST
Afib Asa
III
Superiority Study
Publication
Reference Result
First Line
Therapy
Clopidogrel
Bisulfate
CV149-009 ST
Charisma (Cv149 III
-009)
Clopidogrel For
High
Atherothrombotic
Risk And
Ischemic
Stabilization,
Management And
Avoidance.
Publication
Reference Result
A Phase III,
Multicenter,
Randomized,
Parallel Group,
Double-Blind
Trial Of
Clopidogrel
Versus Placebo
In High-Risk
Patients Aged 45
Years And Older,
At Risk Of
Atherothrmobotic
Events, And Who
Are Receiving
Background
Therapy
Including LowDose Asa.
© 2013 Bristol-Myers Squibb Company.
Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy
3
Heart Failure
Clopidogrel
Bisulfate
CV149-006
WarfarinAntiplatelet
Therapy In
Chronic Heart
Failure Trial
III
Publication
Reference Result
Myocardial
Infarction, Acute
Clopidogrel
Bisulfate
CV149-007
Second Chinese III
Cardiac Study
(Ccs-2). A
Randomized Trial
Of Clopidogrel
Plus Aspirin
Versus Aspirin
Alone, And Of
Metoprolol
Versus Placebo,
Among 2030,000 Patients
With Suspected
Acute Myocardial
Infarction.
Publication
Reference Result
Thrombosis
Eliquis
CV185-077 ST
Protocol Cv 185- I/II
077: Pilot Study
For
Standardization
Of Diagnostic
Techniques For
Central Venous
Catheters Venous
Thromboembolis
m Study
Publication
Reference Result
© 2013 Bristol-Myers Squibb Company.
Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy
4